BACKGROUND: Endothelial dysfunction contributes significantly to the development of vascular diseases. However, a therapy able to reduce this derangement still needs to be identified. We evaluated the effects of pharmacological inhibition of Rac1, a small GTPase protein promoting oxidative stress, in human endothelial dysfunction. METHODS AND RESULTS: We performed vascular reactivity studies to test the effects of NSC23766, a Rac1 inhibitor, on endothelium-dependent vasorelaxation of saphenous vein segments collected from 85 subjects who had undergone surgery for venous insufficiency and from 11 patients who had undergone peripheral vascular surgery. The endothelium-dependent vasorelaxation of the varicose segments of saphenous veins collected from patients with venous insufficiency was markedly impaired and was also significantly lower than that observed in control nonvaricose vein tracts from the same veins. Rac1 activity, reactive oxygen species levels, and reduced nicotine adenine dinucleotide phosphate (NADPH) oxidase activity were significantly increased in varicose veins, and NSC23766 was able to significantly improve endothelium-dependent vasorelaxation of dysfunctional saphenous vein portions in a nitric oxide-dependent manner. These effects were paralleled by a significant reduction of NADPH oxidase activity and activation of endothelial nitric oxide synthase. Finally, we further corroborated this data by demonstrating that Rac1 inhibition significantly improves venous endothelial function and reduces NADPH oxidase activity in saphenous vein grafts harvested from patients with vascular diseases undergoing peripheral bypass surgery. CONCLUSIONS: Rac1 pharmacological inhibition rescues endothelial function and reduces oxidative stress in dysfunctional veins. Rac1 inhibition may represent a potential therapeutic intervention to reduce human endothelial dysfunction and subsequently vascular diseases in various clinical settings.

Rac1 pharmacological inhibition rescues human endothelial dysfunction / Carrizzo, Albino; Vecchione, Carmine; Damato, Antonio; DI NONNO, Flavio; Ambrosio, Mariateresa; Pompeo, Franco; Cappello, Enrico; Capocci, Luca; Peruzzi, Mariangela; Valenti, Valentina; BIONDI ZOCCAI, Giuseppe; Marullo, Antonino; Palmerio, Silvia; Carnevale, Roberto; Spinelli, Chiara C.; Puca, Annibale A.; Rubattu, Speranza Donatella; Volpe, Massimo; Sadoshima, Junichi; Frati, Giacomo; Sciarretta, Sebastiano. - In: JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE. - ISSN 2047-9980. - ELETTRONICO. - 6:3(2017). [10.1161/JAHA.116.004746]

Rac1 pharmacological inhibition rescues human endothelial dysfunction

PERUZZI, MARIANGELA;Valenti, Valentina;BIONDI ZOCCAI, GIUSEPPE;MARULLO, Antonino;CARNEVALE, Roberto;RUBATTU, Speranza Donatella;VOLPE, Massimo;FRATI, GIACOMO;SCIARRETTA, SEBASTIANO
2017

Abstract

BACKGROUND: Endothelial dysfunction contributes significantly to the development of vascular diseases. However, a therapy able to reduce this derangement still needs to be identified. We evaluated the effects of pharmacological inhibition of Rac1, a small GTPase protein promoting oxidative stress, in human endothelial dysfunction. METHODS AND RESULTS: We performed vascular reactivity studies to test the effects of NSC23766, a Rac1 inhibitor, on endothelium-dependent vasorelaxation of saphenous vein segments collected from 85 subjects who had undergone surgery for venous insufficiency and from 11 patients who had undergone peripheral vascular surgery. The endothelium-dependent vasorelaxation of the varicose segments of saphenous veins collected from patients with venous insufficiency was markedly impaired and was also significantly lower than that observed in control nonvaricose vein tracts from the same veins. Rac1 activity, reactive oxygen species levels, and reduced nicotine adenine dinucleotide phosphate (NADPH) oxidase activity were significantly increased in varicose veins, and NSC23766 was able to significantly improve endothelium-dependent vasorelaxation of dysfunctional saphenous vein portions in a nitric oxide-dependent manner. These effects were paralleled by a significant reduction of NADPH oxidase activity and activation of endothelial nitric oxide synthase. Finally, we further corroborated this data by demonstrating that Rac1 inhibition significantly improves venous endothelial function and reduces NADPH oxidase activity in saphenous vein grafts harvested from patients with vascular diseases undergoing peripheral bypass surgery. CONCLUSIONS: Rac1 pharmacological inhibition rescues endothelial function and reduces oxidative stress in dysfunctional veins. Rac1 inhibition may represent a potential therapeutic intervention to reduce human endothelial dysfunction and subsequently vascular diseases in various clinical settings.
2017
cardiovascular disease; endothelial dysfunction; nitric oxide; oxidative stress; cardiology and cardiovascular medicine
01 Pubblicazione su rivista::01a Articolo in rivista
Rac1 pharmacological inhibition rescues human endothelial dysfunction / Carrizzo, Albino; Vecchione, Carmine; Damato, Antonio; DI NONNO, Flavio; Ambrosio, Mariateresa; Pompeo, Franco; Cappello, Enrico; Capocci, Luca; Peruzzi, Mariangela; Valenti, Valentina; BIONDI ZOCCAI, Giuseppe; Marullo, Antonino; Palmerio, Silvia; Carnevale, Roberto; Spinelli, Chiara C.; Puca, Annibale A.; Rubattu, Speranza Donatella; Volpe, Massimo; Sadoshima, Junichi; Frati, Giacomo; Sciarretta, Sebastiano. - In: JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE. - ISSN 2047-9980. - ELETTRONICO. - 6:3(2017). [10.1161/JAHA.116.004746]
File allegati a questo prodotto
File Dimensione Formato  
Carrizzo_Rac1_2017.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.51 MB
Formato Adobe PDF
1.51 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/955277
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 15
social impact